Clinical trials news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Buh-bye FLASH…Hello HTML5! Welcome HTML5 into the New Year Are you ready to make the switch? Hybrid Meetings is! As we pause to say goodbye to 2015, we should remember our old friend FLASH. Often temperamental, a bit vulnerable and a little misunderstood, it’s time to say, “Buh-bye FLASH and Hello HTML5!” With HTML5 stealing the scene on every screen, virtual ... Read More
Sudler & Hennessey Group Acquires Viscira Acquisition Adds Innovative New Media Communications and Technology Horsepower to the Company NEW YORK, March 24, 2016 /PRNewswire/ — Sudler & Hennessey Group, a leading global healthcare communications network, is pleased to announce the acquisition of Viscira, a leader in digital marketing and cutting-edge media in the healthcare space. Viscira develops visually-stunning, interactive solutions that provide unique, ... Read More
Improving the Safety Profile and Efficacy of Drug Formulation for Children Interview with Cheryl Pikora, M.D. Ph.D., MPH, FAAP, Medical Director, Dengue Vaccine Program at Takeda Vaccines. With the continuous changes in both the global regulatory agencies, FDA and EMA, pharmaceutical companies must develop a more comprehensive global compliance and ethics program to ensure patient safety in pediatric clinical trials. In order to ensure a successful pediatric ... Read More
Innovation Corner: Clinical Channel News Clinical Trials Recruitment Clinical Connect Delivers Outreach & Analytics SUMMARY Clinical Connect has access to 60+ million de-identified U.S. health histories that include diagnosis (ICD9/10) and treatment (CPT) data, lab and prescription information, financial and plan data, referral patterns and more. Data overlay of existing client data and inclusion/exclusion criteria help further refine searches. Data feeds are delivered directly ... Read More
7 Things You Must Know When Selecting an Electronic Lab Notebook To help you make a successful ELN selection, download this free, quick guide. Learn how to determine between fact and fiction during pre-purchase demonstrations and other engagements with ELN providers. Ensure that your ELN will maximize the value of the information you capture and scale to meet your cost, resource, performance and business requirements over ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More